About: Practice considerations for proton beam radiotherapy of uveal melanoma during the COVID-19 pandemic: PTCOG Ocular experience

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Practice considerations for proton beam radiotherapy of uveal melanoma during the COVID-19 pandemic: PTCOG Ocular experience Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Practice considerations for proton beam radiotherapy of uveal melanoma during the COVID-19 pandemic: PTCOG Ocular experience
Creator	Ma, Weber, D Afshar, A Be, Damato Char, W Daftari, A Damato, B Dc, Weber Dendale, A Ha, Shih Heufelder, D Hrbacek, R Ik, Daftari Je, Scholey Kacperek, A Kk, Mishra Ma, I Mazal, J Mishra, K Mishra, Kavita Pica, J Sauerwein, Scholey, J Shih, H Thariat, J
Source	Elsevier; Medline; PMC; WHO
abstract	Abstract Uveal melanoma (UM) is a rare but life-threatening cancer of the eye. In light of the COVID-19 pandemic, hospitals and proton eye therapy facilities must analyze several factors to ensure appropriate treatment protocols for patients and provider teams. Practice considerations to limit COVID-19 transmission in the proton ocular treatment setting for UM are necessary. The Particle Therapy Co-Operative Group (PTCOG) is the largest international community of particle/proton therapy providers. Participating experts are/were affiliated with the member institutions of the PTCOG Ocular subcommittee with long-standing high-volume proton ocular programs. The practices reviewed in this document must be taken in conjunction with local hospital procedures, multidisciplinary recommendations, and regional/national guidelines, as each community may have its unique needs, supplies, and protocols. Importantly, as the pandemic evolves, so will the strategies and recommendations. Given the unique circumstances for UM patients, along with indications of potential ophthalmologic transmission as a result of healthcare providers working in close proximity to patients and intrinsic infectious risk from eyelashes, tears and hair, practice strategies may be adapted to reduce the risk of viral transmission. Certainly, providers and health care systems will continue to examine and provide as safe and effective care as possible for patients in the current environment.
has issue date	2020-04-23(xsd:dateTime)
bibo:doi	10.1016/j.adro.2020.04.010
bibo:pmid	32337386
has license	els-covid
sha1sum (hex)	a743680c7d1a31ddbbcd23024ce24a8d14a71ced
schema:url	https://doi.org/10.1016/j.adro.2020.04.010
resource representing a document's title	Practice considerations for proton beam radiotherapy of uveal melanoma during the COVID-19 pandemic: PTCOG Ocular experience
has PubMed Central identifier	PMC7179507
has PubMed identifier	32337386
schema:publication	Adv Radiat Oncol
resource representing a document's body	covid:a743680c7d1a31ddbbcd23024ce24a8d14a71ced#body_text
is schema:about of	named entity 'pandemic' named entity 'COVID-19' named entity 'proton beam' named entity 'COVID-19 pandemic' named entity 'proton beam' named entity 'tumors' named entity 'ophthalmologic' named entity 'metastasis' named entity 'goggles' named entity 'safe and effective' named entity 'Enucleation' named entity 'Co-Operative Group' named entity 'tantalum' named entity 'Metastases' named entity 'telehealth' named entity 'PPE' named entity 'tumor' named entity 'tumors' named entity 'iris' named entity 'asymptomatic' named entity 'COVID-19 pandemic' named entity 'proton beam' named entity 'slit lamp' named entity 'tumors' named entity 'life-threatening' named entity 'proton' named entity 'Proton' named entity 'amputation' named entity 'risk factors' named entity 'tumors' named entity 'bodily fluid' named entity 'tumor' named entity 'level 1' named entity 'salivary fluid' named entity 'loss of vision' named entity 'health care systems' named entity 'triage' named entity 'tumor' named entity 'enucleation' named entity 'curative therapy' named entity 'urgent care' named entity 'radiotherapy' named entity 'ocular oncology' named entity 'quarantine' named entity 'tumor' named entity 'Uveal melanoma' named entity 'eye drops' named entity 'COVID-19' named entity 'proton' named entity 'mucosa' named entity 'infection' named entity 'COVID-19' named entity 'face shield' named entity 'toxicity' named entity 'radiation therapy' named entity 'protective equipment' named entity 'enucleation'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software